Literature DB >> 15491615

Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site.

T Moldoveanu1, R L Campbell, D Cuerrier, P L Davies.   

Abstract

The endogenous calpain inhibitor, calpastatin, modulates some patho-physiological aspects of calpain signaling. Excess calpain can escape this inhibition and as well, many calpain isoforms and autolytically generated protease core fragments are not inhibited by calpastatin. There is a need, therefore, to develop specific, cell-permeable calpain inhibitors to block uncontrolled proteolysis and prevent tissue damage during brain and heart ischemia, spinal-cord injury and Alzheimer's diseases. Here, we report the first high-resolution crystal structures of rat mu-calpain protease core complexed with two traditional, low molecular mass inhibitors, leupeptin and E64. These structures show that access to a slightly deeper, but otherwise papain-like active site is gated by two flexible loops. These loops are divergent among the calpain isoforms giving a potential structural basis for substrate/inhibitor selectivity over other papain-like cysteine proteases and between members of the calpain family.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15491615     DOI: 10.1016/j.jmb.2004.09.016

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  26 in total

Review 1.  The role of calcium-activated protease calpain in experimental retinal pathology.

Authors:  M Azuma; T R Shearer
Journal:  Surv Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 6.048

2.  Synthesis and calpain inhibitory activity of peptidomimetic compounds with constrained amino acids at the P2 position.

Authors:  Isaac O Donkor; Rajani Korukonda
Journal:  Bioorg Med Chem Lett       Date:  2008-07-27       Impact factor: 2.823

3.  Calpain 10 homology modeling with CYGAK and increased lipophilicity leads to greater potency and efficacy in cells.

Authors:  Matthew A Smith; Campbell McInnes; Ryan M Whitaker; Christopher C Lindsey; Richard F Comer; Craig C Beeson; Rick G Schnellmann
Journal:  ACS Chem Biol       Date:  2012-05-31       Impact factor: 5.100

4.  Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors.

Authors:  Isaac T Schiefer; Subhasish Tapadar; Vladislav Litosh; Marton Siklos; Rob Scism; Gihani T Wijewickrama; Esala P Chandrasena; Vaishali Sinha; Ehsan Tavassoli; Michael Brunsteiner; Mauro Fa'; Ottavio Arancio; Pavel Petukhov; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2013-07-22       Impact factor: 7.446

Review 5.  Calpain research for drug discovery: challenges and potential.

Authors:  Yasuko Ono; Takaomi C Saido; Hiroyuki Sorimachi
Journal:  Nat Rev Drug Discov       Date:  2016-11-11       Impact factor: 84.694

6.  CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model.

Authors:  Katherine J Wert; Alexander G Bassuk; Wen-Hsuan Wu; Lokesh Gakhar; Diana Coglan; MaryAnn Mahajan; Shu Wu; Jing Yang; Chyuan-Sheng Lin; Stephen H Tsang; Vinit B Mahajan
Journal:  Hum Mol Genet       Date:  2015-05-20       Impact factor: 6.150

7.  Molecular basis of calpain cleavage and inactivation of the sodium-calcium exchanger 1 in heart failure.

Authors:  Pimthanya Wanichawan; Tandekile Lubelwana Hafver; Kjetil Hodne; Jan Magnus Aronsen; Ida Gjervold Lunde; Bjørn Dalhus; Marianne Lunde; Heidi Kvaløy; William Edward Louch; Theis Tønnessen; Ivar Sjaastad; Ole Mathias Sejersted; Cathrine Rein Carlson
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

8.  Cocrystal structures of primed side-extending alpha-ketoamide inhibitors reveal novel calpain-inhibitor aromatic interactions.

Authors:  Jin Qian; Dominic Cuerrier; Peter L Davies; Zhaozhao Li; James C Powers; Robert L Campbell
Journal:  J Med Chem       Date:  2008-08-15       Impact factor: 7.446

9.  Detecting the active conformation of calpain with calpastatin-based reagents.

Authors:  Dorothy E Croall; Lisa M Vanhooser; Robert E Cashon
Journal:  Biochim Biophys Acta       Date:  2008-08-28

10.  Structures of human calpain-3 protease core with and without bound inhibitor reveal mechanisms of calpain activation.

Authors:  Qilu Ye; Robert L Campbell; Peter L Davies
Journal:  J Biol Chem       Date:  2018-01-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.